Gender-Affirming Care

The U.S. District judge certified a class action on the accommodations issue, which involves access to certain clothing and grooming.

The state contends two U.S. Supreme Court decisions should lead to overturning a ruling saying Florida violated federal laws by prohibiting Medicaid coverage for the treatments.

The 11th Circuit Court of Appeals has yet to decide on a Florida law and regulations that Gov. Ron DeSantis and the Legislature made a priority in 2023 as judges were waiting on the high court to decide this case.

The state contended that a federal discrimination rule improperly sought to override restrictions on trans treatments and threatened money for state health care programs.

Nine bills impacting the trans and nonbinary community have already been proposed in Florida and will be considered during the current state legislative session.

In an executive order about medical care for transgender youth, President Donald Trump called to end "reliance on junk science." But the order itself included claims about gender-affirming care that clash with leading medical research and practice.

Among the restrictions are preventing minors from beginning to receive puberty blockers and hormone therapy for treatment of gender dysphoria.

Meta has announced changes to its content policies, allowing users to call LGBTQ+ people "mentally ill" or "abnormal" without violating platform rules. This move has been criticized by medical experts.

A new analysis of private insurance claims data finds less than 0.1% of youth accessed puberty blockers or hormones for gender transition. This small group has garnered a huge amount of attention from Republican lawmakers in recent years.

With new restrictions on gender-affirming care, prisons confiscate underwear from transgender inmates and compel them to cut their hair.

California-based nonbinary journalist Nico Lang documents the lives of eight transgender, nonbinary, and genderfluid teenagers across the United States, including two trans siblings in Pensacola.

The lawsuit challenged a state Agency for Health Care Administration rule that barred coverage of hormone treatment and puberty blockers. It was later updated to include a state law that similarly prevented Medicaid reimbursement for the treatments.